StockWatch
·
Pharmaceuticals
Quarterly Result30 May 2026, 07:52 pm

Gennex Labs: FY26 Revenue ₹172.74 Mn, Up 25.26% YoY

AI Summary

Gennex Laboratories Ltd's board approved and considered the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The consolidated financial results show a revenue from operations of ₹17274.09 Lacs for the year ended March 31, 2026, compared to ₹13790.30 Lacs for the previous year. Net profit for the period stood at ₹2097.88 Lacs, up from ₹1812.49 Lacs in the previous year. The Board Meeting was held on May 30, 2026, commencing at 4:00 PM and concluding at 7:30 PM.

Key Highlights

  • Gennex Labs' FY26 revenue from operations increased to ₹17274.09 Lacs.
  • The company's net profit for FY26 rose to ₹2097.88 Lacs.
  • Audited standalone and consolidated financial results for FY26 were approved.
  • Board meeting commenced at 4:00 PM and concluded at 7:30 PM on May 30, 2026.